Compliance with antipsychotic treatment.

Compliance with antipsychotic treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Compliance with antipsychotic treatment. Abstract Text:

M Oehl,M Hummer,W W Fleischhacker,

OBJECTIVE: Despite the demonstrated efficacy of antipsychotics the relapse rate among patients with schizophrenia remains high. One major reason for this is non-compliance. In this article we review different factors influencing compliance and discuss possibilities to enhance compliance among schizophrenic patients. METHOD: This review is based on a systematic literature search in Medline. RESULTS: We summarize the four main factors (patient-, environment-, physician- and treatment-related) that influence compliance and discuss possible measures to enhance compliance. Next to many other variables discussed in more detail, it is crucial to ensure a positive doctor-patient relationship and to provide sufficient information about the benefit/risk ratio of the medication as well as about the illness itself to build up and sustain compliance. Significant others should be included into the therapeutic alliance whenever possible. CONCLUSION: Despite many published reports on compliance, it remains to be a problem of eminent clinical relevance. Clinicians must not underestimate it in order to optimize the treatment of patients with schizophrenia.

Compliance with antipsychotic treatment. Publishing Authors By Initials

M Oehl,M Hummer,WW Fleischhacker,

For similar mental disorders: schizophrenia and disorders with psychotic features: schizophrenia research abstracts see: mental disorders: schizophrenia and disorders with psychotic features: schizophrenia research

PUBMED ID PMID:

MEDLINE DATE:

Compliance with antipsychotic treatment. Journal Published:

PUBLICATION TYPE: Review

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME:

Page Numbers: 83-6

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 2000

Compliance with antipsychotic treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

Compliance with antipsychotic treatment. Keywords Mesh Terms:

KEYWORDS: Schizophrenia

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Compliance with antipsychotic treatment. Information

Substance Name: Antipsychotic Agents

Registry Number: 0

Grant and Affiliation Information for Compliance with antipsychotic treatment.

AFFILIATION: Department of Biological Psychiatry, Innsbruck University Clinics, Austria.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Compliance with antipsychotic treatment Related Publications

• Alcohol and/or benzodiazepine use in injured road users.
• Alcohol and/or benzodiazepine use: different accidents--different impacts?
• An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
• Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.
• Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depression.
• Compliance with antipsychotic treatment.
• Conflicting views on conflicts of interest in medicine.
• Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
• Interpretation of the Pandy test.
• Language lateralization in unmedicated patients during an acute episode of schizophrenia: a functional MRI study.
• Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients.
• Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity.
• New drugs for the treatment of schizophrenic patients.
• No evidence for an association between serum cholesterol and the course of depression and suicidality.
• Not Available
• Not Available
• Perspectives on treatment needs in schizophrenia.
• Schizophrenia today: do we know any more and can we treat it better than a decade ago?
• Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
• [Beta blockers in psychiatric diseases. Indications and problems]
• [Blood diseases.]
• [Blood diseases.]
• [Blood diseases.]
• [Cytostatic therapy.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Preleukemic states.]
• [The problems of older people]